KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Shares Issued (2016 - 2020)

Pfizer has reported Shares Issued over the past 9 years, most recently at $206.0 million for Q3 2020.

  • Quarterly Shares Issued rose 274.55% to $206.0 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $455.0 million through Sep 2020, down 1.73% year-over-year, with the annual reading at $425.0 million for FY2020, 7.87% up from the prior year.
  • Shares Issued was $206.0 million for Q3 2020 at Pfizer, up from $34.0 million in the prior quarter.
  • Over five years, Shares Issued peaked at $625.0 million in Q3 2018 and troughed at $34.0 million in Q2 2020.
  • The 5-year median for Shares Issued is $160.0 million (2018), against an average of $205.2 million.
  • Year-over-year, Shares Issued crashed 91.2% in 2019 and then skyrocketed 274.55% in 2020.
  • A 5-year view of Shares Issued shows it stood at $73.0 million in 2016, then skyrocketed by 182.19% to $206.0 million in 2017, then fell by 22.33% to $160.0 million in 2018, then tumbled by 43.12% to $91.0 million in 2019, then surged by 126.37% to $206.0 million in 2020.
  • Per Business Quant, the three most recent readings for PFE's Shares Issued are $206.0 million (Q3 2020), $34.0 million (Q2 2020), and $124.0 million (Q1 2020).